These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38296630)

  • 1. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
    Furian M; Mademilov M; Buergin A; Scheiwiller PM; Mayer L; Schneider S; Emilov B; Lichtblau M; Bitos K; Muralt L; Groth A; Reiser AE; Sevik A; Sheraliev U; Marazhapov NH; Aydaralieva S; Muratbekova A; Tabyshova A; Abdraeva A; Buenzli S; Sooronbaev TM; Ulrich S; Bloch KE
    NEJM Evid; 2022 Jan; 1(1):EVIDoa2100006. PubMed ID: 38296630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Dexamethasone in Preventing Acute Mountain Sickness in COPD Patients: Randomized Trial.
    Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
    Chest; 2018 Oct; 154(4):788-797. PubMed ID: 29909285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial.
    Tan L; Latshang TD; Aeschbacher SS; Huber F; Flueck D; Lichtblau M; Ulrich S; Hasler ED; Scheiwiller PM; Ulrich S; Bloch KE; Furian M
    JAMA Netw Open; 2020 Jun; 3(6):e207940. PubMed ID: 32568400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.
    Nieto Estrada VH; Molano Franco D; Medina RD; Gonzalez Garay AG; Martí-Carvajal AJ; Arevalo-Rodriguez I
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009761. PubMed ID: 28653390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
    J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
    High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters: A Randomized Clinical Trial.
    Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
    JAMA Netw Open; 2019 Feb; 2(2):e190067. PubMed ID: 30794302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P
    High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
    Kayser B; Hulsebosch R; Bosch F
    High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
    High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise limitation of acetazolamide at altitude (3459 m).
    Bradwell AR; Myers SD; Beazley M; Ashdown K; Harris NG; Bradwell SB; Goodhart J; Imray CH; Wimalasena Y; Edsell ME; Pattinson KT; Wright AD; Harris SJ;
    Wilderness Environ Med; 2014 Sep; 25(3):272-7. PubMed ID: 24931587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
    High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
    Ritchie ND; Baggott AV; Andrew Todd WT
    J Travel Med; 2012; 19(5):298-307. PubMed ID: 22943270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
    Lipman GS; Jurkiewicz C; Burnier A; Marvel J; Phillips C; Lowry C; Hawkins J; Navlyt A; Swenson ER
    Am J Med; 2020 Dec; 133(12):e706-e715. PubMed ID: 32479750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial.
    Hillenbrand P; Pahari AK; Soon Y; Subedi D; Bajracharya R; Gurung P; Lal BK; Marahatta R; Pradhan S; Rai D; Sharma S;
    Wilderness Environ Med; 2006; 17(2):87-93. PubMed ID: 16805144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.
    Kayser B; Dumont L; Lysakowski C; Combescure C; Haller G; Tramèr MR
    High Alt Med Biol; 2012 Jun; 13(2):82-92. PubMed ID: 22724610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).
    McIntosh SE; Hemphill M; McDevitt MC; Gurung TY; Ghale M; Knott JR; Thapa GB; Basnyat B; Dow J; Weber DC; K Grissom C
    Wilderness Environ Med; 2019 Mar; 30(1):12-21. PubMed ID: 30630671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
    Carlsten C; Swenson ER; Ruoss S
    High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
    Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.